121
Views
16
CrossRef citations to date
0
Altmetric
Case Report

Chronic mandibular osteomyelitis with suspected underlying synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: a case report

, , , , &
Pages 29-35 | Published online: 27 Feb 2012

Abstract

Chronic mandibular osteomyelitis is an intractable disease. In recent years, some case reports have related this disease process to synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome, which is chronic with frequent remissions and exacerbations. This report describes a case of chronic mandibular osteomyelitis suspected to be SAPHO syndrome. A 68-year-old woman presented with pain on the left side of the mandible. On the basis of clinical and radiological findings, chronic mandibular diffuse sclerosing osteomyelitis was initially diagnosed. We administrated oral clarithromycin (400 mg daily) and levofloxacin (500 mg daily), and her pain subsequently resolved. On 99mTc-labeled methylene diphosphonate scintigraphy, tracer uptake in the asymptomatic mandible was unchanged, but there was increasing tracer uptake in the sternocostal and sternoclavicular joints, compared with 99mTc-labeled methylene diphosphonate scintigraphic findings of the first visit. We diagnosed SAPHO syndrome and administrated oral sodium risedronate hydrate (2.5 mg daily). Although there has been no pain or swelling in the area of the left mandibular lesion, we have followed up on other skin and osteoarticular manifestations in conjunction with other medical departments.

Introduction

Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a disorder characterized by pustular skin lesions and osteoarticular lesions proposed in 1987 by Chamot et al.Citation1 Hyperostosis refers to excessive osteogenesis, which is visualized radiographically as osteosclerosis. Typical skin lesions include palmoplantar pustulosis and severe acne (such as acne conglobata and acne fulminans), or hidradenitis suppurativa.Citation1Citation4 A number of associations between skin conditions and osteoarticular disorders have been reported under a variety of names, including chronic recurrent multifocal osteomyelitis, sternocostoclavicular hyperostosis, pustulotic arthroosteitis, and acne-associated spondyloarthropathy.Citation2,Citation3,Citation5

The SAPHO acronym was proposed to group these various disorders.Citation1,Citation6 SAPHO syndrome is not an independent ailment, but a combination of symptoms,Citation7 as sometimes individual osteoarticular and skin manifestations appear asynchronously.Citation8,Citation9 Some studies have indicated recurrent osteomyelitis of the mandible in almost 10% of patients with SAPHO syndrome.Citation1,Citation6,Citation10 We report here a case of diffuse sclerosing osteomyelitis of the mandible in which SAPHO syndrome was suspected, and we discuss clinicopathological characteristics of the disease based on a review of the literature.

Case

A 68-year-old woman was admitted to our clinic in August 2010 with a 14-month history of pain in the left side of the mandible. One month after treatment of a chronic apical lesion of the mandibular left canine in October 2007, she developed pain in the left side of the mandible. Mandibular osteomyelitis was diagnosed by radiographic and laboratory findings at another hospital in May 2008. She had a history of anemia from 6 to 40 years of age. When she was 66 years old, psoriasis developed on her dorsal, palmar, and plantar skin.

There was no trismus or paresthesia of the left side of the lower lip and chin on her first visit to our clinic. Oral examination showed tooth loss from the left first premolar to the left third molar and no evidence of either mucosal or bone lesions. Panoramic radiography showed osteosclerosis from the left premolar to the mandibular ramus region (). Computed tomography of the head and neck showed enlarged canals of the left mandible and increased density of cancellous bone, which seemed to be reactive bone remodeling (). On magnetic resonance imaging, jaw lesions showed low signal intensity on T1-weighted images and heterogeneous intermediate-to-high signal intensity on fat-suppressed T2-weighted images (). Bone scintigram (99mTc-labeled methylene diphosphonate) showed extremely intense tracer uptake in the left mandible, the sternum, and the sternocostal and sternoclavicular joints (). Mandibular osteomyelitis was diagnosed at the first visit. Because pain had resolved, we followed up for 4 months. She reexperienced pain and trismus. We administrated oral loxoprofen (60 mg daily) for 1 month, and the pain resolved. However, radiographic examination showed development of inflammation in the soft tissue around the left mandibular condyle and resorption of condylar bone (). We empirically started clarithromycin (400 mg daily) and levofloxacin (500 mg daily). Six months later, scintigraphic examination showed almost the same level and range of uptake in the left mandible, and stronger and wider uptake in the sternum and the sternocostal sternoclavicular joints, compared with the findings obtained 1 year earlier (). Laboratory data were in the normal range, except for platelets (323,000; normal range: 128,000–280,000/μL), C-reactive protein (1.26 mg/dL; normal range: <0.30 mg/dL), C3 (321 mg/dL; normal: 86–160 mg/dL), C4 (60.3 mg/dL; normal range: 17–45 mg/dL), and alkaline phosphatase (386 U/L; normal range: 104–338 U/L). She was negative for rheumatoid factor. A presumptive diagnosis of SAPHO was made. After consultation with her physician, we prescribed oral risedronate hydrate (2.5 mg daily). The patient showed no mandibular symptoms 12 months after starting conservative therapy.

Figure 1 Panoramic radiograph at first visit, showing a ground-glass appearance (yellow arrows) from the left premolar to the mandibular ramus region and enlarged canals of the left mandible (red arrow).

Figure 1 Panoramic radiograph at first visit, showing a ground-glass appearance (yellow arrows) from the left premolar to the mandibular ramus region and enlarged canals of the left mandible (red arrow).

Figure 2 Plain computed tomography at first visit revealed increased density of cancellous bone.

Figure 2 Plain computed tomography at first visit revealed increased density of cancellous bone.

Figure 3 Magnetic resonance imaging at first visit.

Note: The left side of the ascending ramus of the mandible shows heterogeneous intermediate-to-high signal intensity on fat-suppressed T2-weighted images.
Figure 3 Magnetic resonance imaging at first visit.

Figure 4 Bone scintigram (99mTc-labeled methylene diphosphonate) at first visit, showing extremely intense tracer uptake in the left side of the mandible, the sternum, and the sternocostal and sternoclavicular joints.

Figure 4 Bone scintigram (99mTc-labeled methylene diphosphonate) at first visit, showing extremely intense tracer uptake in the left side of the mandible, the sternum, and the sternocostal and sternoclavicular joints.

Figure 5 CT and MRI at 4-month follow-up after the first visit: (A) plain CT showing diffuse cortical bone resorption of the left condyle of the mandible; (B) MRI, with the left condyle of the mandible in part showing low-high signal intensity on a T1-weighted image; (C) MRI, with soft tissue around the left side of the ascending ramus of the mandible showing heterogeneous high-signal intensity on a fat-suppressed T2-weighted image.

Abbreviations: CT, computed tomography; MRI, magnetic resonance imaging.
Figure 5 CT and MRI at 4-month follow-up after the first visit: (A) plain CT showing diffuse cortical bone resorption of the left condyle of the mandible; (B) MRI, with the left condyle of the mandible in part showing low-high signal intensity on a T1-weighted image; (C) MRI, with soft tissue around the left side of the ascending ramus of the mandible showing heterogeneous high-signal intensity on a fat-suppressed T2-weighted image.

Figure 6 Bone scintigram 6 months after administration of antibiotics.

Note: Radioisotope uptake in the left mandible is unchanged, while radioisotope uptake in the sternum and in the sternocostal and sternoclavicular joints is increased, compared with the images of the first visit.
Figure 6 Bone scintigram 6 months after administration of antibiotics.

Discussion

Etiology and pathogenesis

The prevalence of SAPHO syndrome has been estimated to be probably no greater than one in 10,000 in CaucasiansCitation11 and to be 0.00144 in 100,000 in Japanese.Citation12 Hayem et alCitation6 reviewed 120 cases of SAPHO syndrome. They described female predominance with patients younger than 30 years at onset, anterior chest wall as the most commonly affected bone-lesion site, peripheral arthritis in one-third of patients, and pustular dermatitis as a frequent complication. Yabe et alCitation13 reported that most of the Japanese patients exhibited onset in middle age. In addition, differences between Caucasians and Japanese may be an influential factor.

The most common target site for bone lesions in adults is the anterior chest wall, in particular the clavicles, sternum, and sternoclavicular joints (70%–90% of patients), followed by the sacroiliac region (40% of patients), the spine (33% of patients), the mandible (almost 10% of patients), and the pubic symphysis (7% of patients).Citation6,Citation8,Citation11,Citation14

Adequate data on the prevalence of this syndrome are unavailable because of diverse clinical manifestations and lack of validated classification or diagnostic criteria. Preliminary criteria need improvement and further validation.Citation15

It is presumed that the osteitis and skin lesions seen in SAPHO syndrome are the results of sustained but low-grade infection with anerobic microorganisms such as Propionibacterium acnes odontogenic focal infection,Citation16 which persist in the osteitis lesions in a form that is incompatible with culturing, but triggers a nonspecific activation/ dysfunction of innate and T-cell-mediated immune responses in genetically predisposed individuals.Citation14

It has been suggested that SAPHO syndrome represents hyperstimulation of the innate immune response in these disorders, as reflected by increased production of interleukin-8 and tumor necrosis factor-α.Citation16 It has also been suggested that a possible genetic abnormality with a pathogenic role might be characterized by impaired production of an internal oxidant, with subsequent exaggerated inflammatory response causing SAPHO syndrome.Citation17 However, this hypothesis is largely unproven.Citation14 One report that suggested a chronic apical lesion on a mandibular first molar might be associated with the occurrence of SAPHO syndrome.Citation18 In this case, the patient had experienced a chronic apical lesion of the mandibular left canine before diagnosis of mandibular osteomyelitis. Dental foci could serve as the origin of the mandibular osteomyelitis and osteitis of the sternum and sternocostal and sternoclavicular joints.

Diagnosis of SAPHO syndrome

The distinct clinical features of SAPHO syndrome are skin and osteoarticular manifestations. The skin manifestations may precede or follow the bone lesions, usually by years but in some cases more than a decade.Citation3,Citation4,Citation19 Diagnosis of SAPHO can be difficult in the absence of skin lesions or involvement with only one symptomatic bone site.Citation20

When SAPHO syndrome is suspected or diagnosed, the patient should undergo systemic whole-body technetium scintigraphy to exclude other asymptomatic lesions. In this case, we could not have found the asymptomatic osteitis of the sternum and sternocostal and sternoclavicular joints before bone scintigram.

Suei et alCitation9 suggest that the original site of osteomyelitis in SAPHO syndrome is not bone but periosteum. Proinflammatory cytokines such as interleukin-8 and tumor necrosis factor-α are produced in the inflamed periosteum and stimulate osteoblasts and osteoclasts by promoting periosteal bone formation in addition to cortical bone resorption. They suggest that radiographic findings vary in osteomyelitis associated with SAPHO syndrome.Citation9 Mixed patterns with initial osteolyses and diffuse sclerosis, bone enlargement with extensive cortical bone resorption, and solid periosteal reaction have been reported frequently in osteomyelitis of SAPHO syndrome.Citation9,Citation21 Our case constituted diffuse cortical bone resorption of the left condyle of the mandible and reactive sclerosis of the subcondylar bone. Routine blood tests reveal elevated acute phase reactants, such as C-reactive protein, erythrocyte sedimentation rate, and elevated levels of complements C3 and C4, as seen in our case.Citation14 Zhao et alCitation22 reported that a moderately increased leukocyte count, mild anemia and an elevated erythrocyte sedimentation, and elevated level of immunoglobulin A were observed.

Treatment

The treatment of SAPHO syndrome is empirical and based on anecdotal experiences or small control studies.Citation23 There are currently no guidelines, so the treatment for SAPHO syndrome has focused mainly only on symptoms and complaints, such as bone pain and tenderness.Citation24 Conservative treatment, such as with drugs and/or hyperbaric oxygen, is recommended as a first-line therapy.

Drugs

Based on the assumption that P. acnes is involved in the pathogenesis of SAPHO syndrome, antibiotic therapy and NSAIDs have been used to treat SAPHO syndrome, with varying success.Citation15 It has also been reported that clindamycin and tetracycline were effective.Citation7,Citation25,Citation26 According to some recent reports, macrolides or new quinolones effectively inhibit the production of various inflammatory cytokines, such as interleukin-1, -6, -8, and tumor necrosis factor-α.Citation27,Citation28 For a drug combination, SchillingCitation29 recommended azithromycin, which has both anti-inflammatory and immunomodulating activity, and calcitonin, which is a hormonal osteotropic drug. However, we could not detect previous reports of effectiveness of combination of macrolides and new quinolones, as we used in this case. The effectiveness of our combined regimens should be further studied. Some studies have reported the effectiveness of corticosteroids or bisphosphonates for SAPHO syndrome.Citation29,Citation30 Because these drugs have systemic pharmacological functions and serious side effects, oral surgeons should consult closely with other physicians in the use of these medications.Citation30 The decision of when to stop administration of drugs seems to depend on each patient’s degree of improvement of clinical symptoms, such as pain, range of trismus, and radiographic findings. In the absence of additional osteolytic change in bone lesions, along with the resolution of symptoms, treatment may be presumed effective for chronic mandibular diffuse sclerosing osteomyelitis, even if osteosclerosis remains unchanged.Citation27

Surgery

The recurrence rate after decortication treatment or partial resection of the affected bone is reported to be high.Citation30Citation32 Roldán et alCitation26 reported a case of SAPHO syndrome with ineffective decortications; therefore, surgical intervention is not recommended.Citation33 Wide resection of the affected mandibular bone and immediate reconstruction using microvascular flaps seems to be recommended only if a patient experiences deformity, loss of function, increasing pain, and failure of conservative treatments.Citation10 The bone donor site for mandibular reconstruction in a SAPHO patient could also be affected by osteomyelitis. Long bones are affected by SAPHO syndrome in 30% of cases,Citation1 mostly involving the femur and the tibia.Citation34 In 10% of cases, the ilium is affected. Involvement of the donor site should be excluded by 99mTc-labeled methylene diphosphonate scintigraphy and strictly followed up according to future involvement of the transplanted bone.

Prognosis

SAPHO syndrome is chronic, with frequent remissions and exacerbations. It has been reported that cases of chronic mandibular diffuse sclerosing osteomyelitis that have extended to the ascending ramus of the mandible tend to take longer for resolution of symptomsCitation27 and have a higher rate of recurrence.Citation35 In our case, although there has been no pain or swelling in the area of the left mandibular lesion, we have followed up to prevent lesions from developing other skin or osteoarticular manifestations.

SAPHO syndrome may be occasionally confused with malignancy or infection, and some patients may undergo unnecessary invasive procedures.Citation20,Citation36 A high index of clinical suspicion of SAPHO syndrome is necessary for accurate diagnosis.Citation20 Oral surgeons must consult with physicians in such specialties as dermatology, orthopedics, and internal medicine when SAPHO syndrome is suspected.

Conclusion

Although this report is based on a single case, it provides information on one of the treatments – specifically, the combination of macrolides or new quinolones and bisphosphonates – for intractable chronic mandibular osteomyelitis that was suspected to be SAPHO syndrome.

Acknowledgments

The authors would like to thank the patient, nurses, and other medical staff.

Disclosure

The authors report no conflicts of interest in this work.

References

  • ChamotAMBenhamouCLKahnMFBeraneckLKaplanGProstAAcne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 casesRev Rhum Mal Osteoartic19875431871962954204
  • ChigiraMShimizuTComputed tomographic appearances of sternocostoclavicular hyperostosisSkeletal Radiol19891853473522789434
  • SonozakiHAzumaAOkaiKClinical features of 22 cases with “inter-sterno-costo-clavicular ossification.” A new rheumatic syndromeArch Orthop Trauma Surg1979951–21322118719
  • LaasonenLSKarvonenSLReunalaTLBone disease in adolescents with acne fulminans and severe cystic acne: radiologic and scintigraphic findingsAJR Am J Roentgenol19941625116111658166004
  • SonozakiHMitsuiHMiyanagaYClinical features of 53 cases with pustulotic arthro-osteitisAnn Rheum Dis19814065475537332374
  • HayemGBouchaud-ChabotABenaliKSAPHO syndrome: a long-term follow-up study of 120 casesSemin Arthritis Rheum199929315917110622680
  • Müller-RichterUDARoldanJCMörtlMBehrMReichertTEDriemelOSAPHO syndrome with ankylosis of the temporomandibular jointInt J Oral Maxillofac Surg200938121335134119660913
  • EarwalkerJWCottonCASAPHO: syndrome or concept? Imaging findingsSkeletal Radiol200332631132712719925
  • SueiYTaguchiATanimotoKDiagnosis and classification of mandibular osteomyelitisOral Surg Oral Med Oral Pathol Oral Radiol Endod2005100220721416037779
  • ZemannWPauMFeichtingerMFerra-MatschyBKaercherHSAPHO syndrome with affection of the mandible: diagnosis, treatment, and review of literatureOral Surg Oral Med Oral Pathol Oral Radiol Endod2011111219019520674419
  • KahnMFKhanMAThe SAPHO syndromeBaillieres Clin Rheumatol1994823333628076391
  • HukudaSMinamiMSaitoTSpondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis SocietyJ Rheumatol200128355454911296958
  • YabeHOhshimaHTakanoYMucosal lesions may be a minor complication of SAPHO syndrome: a study of 11 Japanese patients with SAPHO syndromeRheumatol Int201030101277128319774382
  • ColinaMGovoniMOrzincoloCTrottaFClinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjectsArthritis Care Res2009616813821
  • MagreyMKhanMANew insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndromeCurr Rheumatol Rep200911532933319772827
  • Hurtado-NedelecMChollet-MartinSNicaise-RolandPCharacterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndromeRheumatology (Oxford)20084781160116718559374
  • FergusonPJLokutaMAEl-ShantiHIMuhleLBingXHuttenlocherANeutrophil dysfunction in a family with a SAPHO syndrome-like phenotypeArthritis Rheum200858103264326918821685
  • KahnMFBouvierMPalazzoETebibJGColsonFSternoclavicular pustulotic osteitis (SAPHO). 20-year interval between skin and bone lesionsJ Rheumatol1991187110411081920317
  • YamamotoTYamamotoSUmemuraMShibataAMakinoSChronic mandibular osteomyelitis with suspected relation to palmoplantar pustulosisAichi Gakuin Daigaku Shigakkai Shi20104829398 Japanese
  • Karadag-SaygiEGunduzOHGumrukcuGAkyuzGSAPHO syndrome: misdiagnosed and operatedActa Reumatol Port200833446046319078862
  • SueiYTaguchiATanimotoKDiffuse sclerosing osteomyelitis of the mandible: its characteristics and possible relationship to synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndromeJ Oral Maxillofac Surg19965410119412008859238
  • ZhaoZLiYLiYZhaoHLiHSynovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with review of the relevant published workJ Dermatol201138215515921269311
  • OlivieriIPadulaAPalazziCPharmacological management of SAPHO syndromeExpert Opin Investig Drugs2006151012291233
  • YanamotoSKawasakiGYoshitomiIMizunoADiffuse chronic sclerosing osteomyelitis of the mandible with synovitis, acne, pustulosis, hyperostosis, and osteitis: report of a long-term follow-up caseJ Oral Maxillofac Surg201068121221720006181
  • UtumiEROliveira SalesMAShinoharaEHSAPHO syndrome with temporomandibular joint ankylosis: clinical, radiological, histopathological, and therapeutical correlationsOral Surg Oral Med Oral Pathol Oral Radiol Endod20081053e67e7218280950
  • RoldánJCTerheydenHDunscheAKampenWUSchroederJOAcne with chronic recurrent multifocal osteomyelitis involving the mandible as part of the SAPHO syndrome: case reportBr J Oral Maxillofac Surg200139214114411286450
  • YoshiiTNishimuraHYoshikawaTTherapeutic possibilities of long-term roxithromycin treatment for chronic diffuse sclerosing osteomyelitis of the mandibleJ Antimicrob Chemother200147563163711328775
  • TsudaTIshikawaCKonishiHEffect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease-activated receptor 2 in human keratinocytesJ Antimicrob Chemother200852415381541
  • SchillingFSAPHO syndromeOrphanet Encyclopaedia [serial on the Internet]200410 Available from: http://www.orpha.net/data/patho/GB/uk-SAPHO.pdfAccessed February 17, 2009
  • HatanoHShigeishiHHigashikawaKA case of SAPHO syndrome with diffuse sclerosing osteomyelitis of the mandible treated successfully with prednisolone and bisphosphonateJ Oral Maxillofac SurgAugust 22011 [Epub ahead of print.]
  • JurikAGMollerBNChronic sclerosing osteomyelitis of the clavicle. a manifestation of chronic recurrent multifocal osteomyelitisArch Orthop Trauma Surg198710631441513606353
  • MontonenMIizukaTHallikainenDLindqvistCDecortication in the treatment of diffuse sclerosing osteomyelitis of the mandible. Retrospective analysis of 41 cases between 1969 and 1990Oral Surg Oral Med Oral Pathol19937515118419875
  • EyrichGKHHarderCSailerHFLangeneggerTBruderEMichelBAPrimary chronic osteomyelitis associated with synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO syndrome)J Oral Pathol Med1999281045646410551743
  • MylonaEGolfinopoulouSPeppasCFanourgiakisPSkoutelisAFemoral and lower costosternal junctions’ osteitis in an adult with SAPHO syndrome: an unusual presentationJoint Bone Spine200875333834017983830
  • JacobssonSDiffuse sclerosing osteomyelitis of the mandibleInt J Oral Surg19841353633856437998
  • Van DoornumSBarracloughDMcCollGWicksISAPHO: rare or just not recognized?Semin Arthritis Rheum2000301707710966214